Literature DB >> 17026663

Application of a pigment measuring device--Mexameter--for the differential diagnosis of vitiligo and nevus depigmentosus.

Eun Sang Park1, Jung Im Na, Seon Ok Kim, Chang Hun Huh, Sang Woong Youn, Kyoung Chan Park.   

Abstract

BACKGROUND/
PURPOSE: Vitiligo and nevus depigmentosus (ND) present similar hypopigmented macules with significantly different prognoses. Although the distinction between the two diseases is important, differential diagnosis relies on medical history and physical examination, which is far from decisive in some cases. The Mexameter is an objective skin color-measuring device, and has been reported to provide a reproducible and sensitive means of quantifying small skin color differences. In this study, we investigated the usefulness of a Mexameter for discriminating these diseases.
METHODS: A selection of 202 hypopigmented skin lesions (182 from vitiligo and 20 from ND) were the objects of this study. Using a Mexameter, MIs were obtained from lesions and symmetrically located control skin. RMIs, ratios of the MIs of lesional skins to control skins, were calculated.
RESULTS: The mean MIs and RMIs were significantly different for vitiligo and ND. The mean RMI of ND lesions was 74+/-13, which was significantly higher than that of vitiligo lesions (50+/-24). No ND lesion had an RMI of <50%.
CONCLUSION: This study shows that the Mexameter, an objective pigment-measuring device, can be used to achieve a more accurate diagnosis of hypopigmentary disorders, and that the relative melanin index (RMI), which represents the relative pigment levels, might be a more effective parameter than the melanin index (MI) itself for comparing pigmentation differences.

Entities:  

Mesh:

Year:  2006        PMID: 17026663     DOI: 10.1111/j.0909-752X.2006.00187.x

Source DB:  PubMed          Journal:  Skin Res Technol        ISSN: 0909-752X            Impact factor:   2.365


  6 in total

1.  Vitiligo Coexistent with Nevus Depigmentosus: This Was Treated with Narrow-Band UVB and These Lesions Were Followed Using the Mexameter®, a Pigment-Measuring Device.

Authors:  Seon-Wook Hwang; Ju-Hyun Kang; So-Young Jung; Joon-Hee Choi; Jong-Keun Seo; Deborah Lee; Ho-Suk Sung
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

2.  Quantitative assessment of radiodermatitis through a non-invasive objective procedure in patients with breast cancer.

Authors:  Maiko Kitajima; Kasumi Mikami; Yuka Noto; Chieko Itaki; Yasuyo Fukushi; Yoshiko Hirota; Yasushi Mariya; Megumi Tsushima; Keiichi Kattou; Tomohiro Osanai
Journal:  Mol Clin Oncol       Date:  2019-11-11

3.  Comparative Study on Depigmenting Agents in Skin of Color.

Authors:  Achala Liyanage; Gayani Liyanage; Ganga Sirimanna; Nanna Schürer
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

4.  The Effect of Electroporation of a Lyotroic Liquid Crystal Genistein-Based Formulation in the Recovery of Murine Melanoma Lesions.

Authors:  Corina Danciu; Szilvia Berkó; Gábor Varju; Boglárka Balázs; Lajos Kemény; István Balázs Németh; Andreea Cioca; Alexandra Petruș; Cristina Dehelean; Citu Ioan Cosmin; Elena Amaricai; Claudia Crina Toma
Journal:  Int J Mol Sci       Date:  2015-07-08       Impact factor: 5.923

5.  Neurokinin-1 receptor is a novel positive regulator of Wnt/ β-catenin signaling in melanogenesis.

Authors:  Jia Zhou; Jingjing Ling; Huizhu Song; Bei Lv; Lei Wang; Jing Shang; Yong Wang; Chunyan Chang; Fengfeng Ping; Jun Qian
Journal:  Oncotarget       Date:  2016-12-06

6.  Comparative Measurement of Biophysical Parameters in Consideration of Skin Graft Donor Site for Nasal Defects.

Authors:  Joo-Hak Kim; Chang Hwan Ahn; Sungmin Kim; Young Lee; Sang-Ha Oh
Journal:  Ann Dermatol       Date:  2019-01-02       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.